Comprehensive Geriatric Assessment study to determine an appropriate therapy for elderly patients with diffuse large B-cell lymphoma

Comprehensive Geriatric Assessment study to determine an appropriate therapy for elderly patients with diffuse large B-cell lymphoma - CGAL study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025231

Enrollment

150

Registered

2016-12-12

Start date

2013-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse large B-cell lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Newly-diagnosed untreated patient with histologically-proven DLBCL A patient who gives an informed consent to participate in this study

Exclusion criteria

Exclusion criteria: A patient who is judged inadequate for this study by his/her physician

Design outcomes

Primary

Measure	Time frame
Relationship between CGA results and treatment outcomes(G3,4,5 adverce events)	—

Secondary

Measure	Time frame
1)Average relative dose intensity (ARDI) 2)Treatment completion rate 3)Complete response (CR) 4)Event-free survival(EFS) 5)Overall survival (OS) 6)Cause of death	—

Countries

Japan

Contacts

Public ContactKazuo Tamura

Fukuoka University Division of Medical Oncology, Hematology and Infectious Disease

ktamura@fukuoka-u.ac.jp092-801-1011

Outcome results